MUSTANG BIO, INC. Net Rentable Area
MUSTANG BIO, INC. (MBIO) had Net Rentable Area of 11.92 thousand sqft as of 2023-06-15, per its 10-K filed 2025-03-28.
Financial Statements › Notes
us-gaap:NetRentableArea · last filed 2025-03-28
- 2023-06-15: Net Rentable Area 11.92K sqft.
- 2023-06-14: Net Rentable Area 26.50K sqft.
- 2022-06-14: Net Rentable Area 26.50K sqft.
- 2017-10-27: Net Rentable Area 27.04K sqft.
| Period end | Net Rentable Area |
|---|---|
| 2023-06-15 | 11.92K sqft 10-K · filed 2025-03-28 |
| 2023-06-14 | 26.50K sqft 10-K · filed 2025-03-28 |
| 2022-06-14 | 26.50K sqft 10-K · filed 2025-03-28 |
| 2017-10-27 | 27.04K sqft 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |